期刊文献+

常规疗法加螺内酯治疗慢性充血性心力衰竭的疗效观察

Obsevvation on regular treatment and spironolactone to cure chronic heart failure
下载PDF
导出
摘要 目的:观察常规疗法加螺内酯治疗心力衰竭的效果,改善心衰病人的生活质量。方法:选择门诊及住院的心衰病人62例,随机分为观察组和对照组,对照组用心衰的常规治疗方法,观察组是在常规治疗方法的基础上加用螺内酯40mg/日口服。结果:两组病人血清钾稳定,观察组较对照组住院频率明显减低、结论:在常规治疗的基础上加用螺内酯可降低心衰病人的住院频度,明显减少心衰病人室性心律失常的发生,无高钾血症发生。 Objective:To survey regular treantment and spironolactone to cure heart failure patient effective.Methods:It was analysed sixty-two patients from outpatient and inpatient,they were classified in two group with observation group and contrast,The contrast group use regular treantment with heart failure,the other group use regular treatment and take spironolactone orally 40 mg everyday.Results:the serum kalium were stabilization inboth group,the rate of being in hopsital in observation group were less than confroled groupConclusion:inpatient cases of observation group obvious lessen,the intrarentricular cardiac arrhythmia of heart failure patient decreased obviously,none take place high potassium blood sydrome.
作者 孙景丽
出处 《航空航天医药》 2005年第2期10-11,共2页 Aerospace Medicine
关键词 心衰 常规疗法 螺内酯 heart failure regular treatment spironolactone
  • 相关文献

参考文献3

二级参考文献13

  • 1Bedecs K,Elbaz N,Sutren M,et al.Angiotensin II type receptors mediate inhibition of mitogen activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase[].Biochemical Journal.1997
  • 2Liu Y,Leri A,Li B,et al.Angiotensin II stimulation in vitro induces hypertrophy of normal and postinfarcted ventricular myocytes[].Circulation Research.1998
  • 3Zini S,Fournie-Zaluski MC,Chauvel E,et al.Identification of metabolic pathways of brain angiotensin Ⅱ and Ⅲ using specific aminopeptidase inhibitors: predominant role of angiotensin Ⅲ in the control of vasopressin release[].Proceedings of the National Academy of Sciences of the United States of America.1996
  • 4Bartunek J,Weinberg EO,Tajima M,et al.Angiotensin II type 2 receptor blockade amplifies the early signals of cardiac growth response to Angiotensin II in hypertrophied hearts[].Circulation.1999
  • 5Unger T.Neurohormonal modulation in cardiovascular disease[].American Heart Journal.2000
  • 6Dell′Italia LJ,Meng QC,Balcells E,et al.Compartmentalization of angiotensin II generation in the dog heart.Evidence for independent mechanisms in intravascular and interstitial spaces[].The Journal of Clinical Investigation.1997
  • 7Ping L,Chappell MC,Ferrario CM,et al.Angiotensin (1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide[].Journal of Hypertension.1997
  • 8Moeller I,Small DH,Reed G,et al.Angiotensin Ⅳ inhibits neurite outgrowth in cultured embryonic chicken sympathetic neurons[].Brain Research.1996
  • 9Wei CC,Meng QC,Palmer R,et al.Evidence for angiotensin converting enzyme and chymase mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo[].Circulation.1999
  • 10Bartels GL,Heuvel AdF,Veldhuisen DJ,et al.Acute anti-ischemic effects of perindoprilat in men with coronary artery disease and their relation with left ventricular function[].The American Journal of Cardiology.1999

共引文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部